-+ 0.00%
-+ 0.00%
-+ 0.00%

Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share

PUBT·04/17/2026 00:00:19
Listen to the news
Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share
  • Enveric Biosciences entered definitive agreements for an at-the-market private placement of 2,222,223 common shares, or pre-funded warrants, priced at USD 2.25 per share.
  • Gross proceeds expected at about USD 5 million, before fees.
  • Offering includes Series I warrants, short-term Series J warrants for up to 2,222,223 shares each, exercisable at USD 2 per share.
  • Warrant exercise could raise up to about USD 8.9 million in additional gross proceeds.
  • Closing targeted on or about April 17, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604162000BIZWIRE_USPR_____20260416_BW777063) on April 17, 2026, and is solely responsible for the information contained therein.